Pharmaceutical Safety Assessment Market Report 2026

Pharmaceutical Safety Assessment Market Overview

• Pharmaceutical Safety Assessment market size has reached to $11.32 billion in 2025 • Expected to grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment • Market Trend: AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the pharmaceutical safety assessment market include: • In-Vitro Safety Assessment (Segmentation By Type) → Expected gain of $3.05 Billion • In-Vivo Safety Assessment (Segmentation By Type) → Expected gain of $2.04 Billion • Computational Safety Assessment (Segmentation By Type) → Expected gain of $0.56 Billion

What Is Covered Under Pharmaceutical Safety Assessment Market?

Pharmaceutical safety assessment is the systematic evaluation of drugs and pharmaceutical products to ensure their safety and minimize potential risks to patients. It involves analyzing preclinical and clinical data, monitoring adverse effects, and ensuring compliance with regulatory standards. This process helps in making informed decisions regarding the approval, labeling, and safe use of medications. The main types in the pharmaceutical safety assessment market are in-vitro safety assessment, in-vivo safety assessment, and computational safety assessment. In-vitro safety assessment refers to the evaluation of the safety and toxicity of drugs, chemicals, or other substances using controlled laboratory tests performed outside of a living organism. The various types of drugs include biological drugs and chemical drugs. It spans multiple phases, such as preclinical, clinical (phase I, II, III), and post-market surveillance (phase IV). Key end users include pharmaceutical companies, biotechnology firms, medical device manufacturers, academic and research institutions, and contract research organizations (CROs).

What Is The Pharmaceutical Safety Assessment Market Growth Forecast?

The pharmaceutical safety assessment market size is expected to see strong growth in the next few years. It will grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing reliance on computational safety assessment, expansion of personalized medicine development, rising demand for faster regulatory approvals, growing integration of ai in drug safety workflows, increased post-market surveillance requirements. Major trends in the forecast period include increasing use of ai-based toxicity prediction tools, rising adoption of in-silico safety assessment models, growing integration of real-time pharmacovigilance systems, expansion of automated preclinical testing platforms, enhanced focus on regulatory-compliant safety analytics.

What Is The Driver Of The Pharmaceutical Safety Assessment Market?

The expansion of clinical trials is expected to propel the growth of the pharmaceutical safety assessment market going forward. Clinical trials refer to research studies conducted in humans to evaluate the safety, effectiveness, and side effects of new medical treatments, drugs, or interventions. Clinical trials are rising due to the growing need for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials support pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing essential data that regulatory authorities use to ensure that medications are both effective and safe for public use. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, as of September 26, 2025, a total of 554,798 studies were registered on ClinicalTrials.gov. Therefore, the expansion of clinical trials is driving the growth of the pharmaceutical safety assessment industry.

How Will The Drivers Impact Growth In The Global Pharmaceutical Safety Assessment Market?

• Growing Demand For New Drugs And Biologics (Low) – During the forecast period, the growing demand for new drugs and biologics is expected to become a key growth driver for the pharmaceutical safety assessment market by 2030. The increasing demand for novel drugs and biologics is propelled by the rising prevalence of chronic and infectious diseases, expanding aging populations, and the growing complexity of healthcare needs worldwide. Progress in biotechnology has significantly accelerated biologics development, thereby increasing the need for comprehensive safety assessments. Furthermore, the advancement of personalized medicine and rare disease treatments is driving innovation, requiring thorough safety evaluations to comply with stringent regulatory requirements. • Rising Prevalence Of Chronic Diseases Globally (Medium) – During the forecast period, the rising prevalence of chronic diseases globally is expected to emerge as a major factor driving the expansion of the pharmaceutical safety assessment market by 2030. The worldwide increase in chronic conditions such as diabetes, cancer, and cardiovascular diseases is fueling demand for sustained and innovative therapeutic solutions. This growing need accelerates the requirement for comprehensive pharmaceutical safety assessments to ensure drug effectiveness while reducing potential long-term adverse effects. Since chronic illnesses often require ongoing treatment, continuous safety evaluation and monitoring remain critical throughout the entire drug lifecycle. • Rise In Pharmaceutical R&D Spending And Drug Development Pipelines (High) – During the forecast period, the rise in pharmaceutical r&d spending and drug development pipelines is expected to act as a key growth catalyst for the pharmaceutical safety assessment market by 2030. Rising investment in pharmaceutical research and development, along with expanding drug pipelines, highlights the global drive toward innovative therapies and accelerated approval processes. As a growing number of drug candidates progress through preclinical and clinical stages, the need for detailed safety assessments intensifies. At the same time, increasingly stringent regulatory requirements make comprehensive safety evaluation an essential component of the drug development process.

How Will The Restraints Impact Growth In The Global Pharmaceutical Safety Assessment Market?

• High Costs Associated With Safety Testing (High) – During the forecast period, the safety testing involves extensive preclinical and clinical evaluations, use of advanced technologies, and compliance with strict regulatory standards—all of which significantly increase costs. Smaller pharmaceutical companies often struggle with these financial burdens, limiting their ability to conduct thorough safety assessments. These high costs can also delay drug development timelines and reduce overall r&d efficiency. • Complex Regulatory Landscape And Compliance Requirements (High) – During the forecast period, the pharmaceutical safety assessment market faces challenges due to varying and constantly evolving regulatory requirements across regions. Companies must navigate complex guidelines from agencies like the fda, ema, and others, which demand extensive documentation and rigorous safety data. Ensuring compliance adds time, cost, and operational burden, especially for global drug developers. • Data Security And Privacy Concerns (Medium) – During the forecast period, the pharmaceutical safety assessments involve handling sensitive patient data and proprietary drug information, making data security and privacy critical concerns. Breaches or unauthorized access can lead to regulatory penalties, reputational damage, and loss of intellectual property. As digital tools and cloud-based systems become more prevalent, ensuring robust cybersecurity and compliance with data protection laws like gdpr becomes increasingly challenging.

Key Players In The Global Pharmaceutical Safety Assessment Market

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Global Pharmaceutical Safety Assessment Market Trends and Insights

Major companies in the pharmaceutical safety assessment market are focusing on developing AI-powered decision support tools to enhance the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that uses artificial intelligence to analyze data and provide insights that support faster and more accurate decision-making. For instance, in April 2024, Charles River Laboratories, a US-based life sciences company, in partnership with Deciphex, an Ireland-based company enhances diagnostic precision and speed through AI-driven quality assurance, launched the Patholytix Foresight platform, an AI-powered decision support tool, designed to transform toxicologic pathology in pharmaceutical safety assessment. The platform uses artificial intelligence to quickly analyze complex preclinical pathology data, helping identify potential safety risks earlier and reducing subjectivity in results. It offers unique features such as an AI algorithm that detects tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that cuts down slide review time while improving data accuracy and consistency.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market?

In January 2025, Groupe ProductLife S.A.S., a France-based life sciences services company, acquired Stragen Services SAS for an undisclosed amount. With this acquisition, ProductLife Group aims to enhance its pharmacovigilance and clinical safety capabilities, expand its European market presence, and provide more comprehensive regulatory and safety support to pharmaceutical and biotech clients. Stragen Services SAS is a France-based company that specializes in pharmaceutical safety assessment, also known as pharmacovigilance.

What Defines the Pharmaceutical Safety Assessment Market?

The pharmaceutical safety assessment market includes revenues earned by entities by providing services such as post-marketing surveillance, safety pharmacology, regulatory consulting and compliance, bioanalytics and biomarker services, and in silico and computational toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Safety Assessment Market Report 2026?

The pharmaceutical safety assessment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical safety assessment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.